Elevance Health (NYSE: ELV) has announced the closing of its acquisition of BioPlus, a comprehensive specialty pharmacy subsidiary of CarepathRx, a portfolio company of Nautic Partners. BioPlus provides a complete range of specialty pharmacy services for patients living with complex and chronic conditions, such as cancer, multiple sclerosis, hepatitis C, autoimmune diseases, and rheumatology. The company covers more than 100 limited distribution medications and has a footprint that touches all 50 states. BioPlus will now operate as part of CarelonRx, Elevance Health’s pharmacy benefit manager within Carelon.
Read the full article: Elevance Health Announces Closing of BioPlus Acquisition
Source: https://www.businesswire.com/news/home/20230214005812/en/Elevance-Health-Announces-Closing-of-BioPlus-Acquisition